Werner Lanthaler

Werner Lanthaler is a prominent figure in the biotechnology and pharmaceutical industry with extensive experience in leadership roles. He is currently the Managing Director of W.Lan Holding GmbH, an advisory and investment firm.16

Career Highlights

Evotec AG:: Lanthaler served as the CEO of Evotec AG from February 2009 to January 2024.13 During his tenure, he focused on collaborating with biotech and pharma companies and academia, supporting biotech innovation.1

Intercell AG:: Prior to joining Evotec, Lanthaler was the Chief Financial Officer at Intercell AG, a global biopharmaceutical company specializing in vaccine development.12 He played a crucial role in the company's major milestones, including its IPO and transformation from a venture-backed biotech to a global vaccine player.1

Other Roles::

• Director of the Federation of Austrian Industry
• Senior Management Consultant at McKinsey & Company (1995-1998)1

Board Positions

• Non-Executive Member of the Board of Directors of arGEN-X
• Member of the Supervisory Board of Topas Therapeutics GmbH1
• Head of the Proxygen Supervisory Board4

Education

• Doctorate in Economics from Vienna University
• Master's degree in Business Administration from Harvard University
• Degree in Psychology13

Werner Lanthaler's extensive experience in the biotech and pharmaceutical industries, combined with his leadership roles and educational background, make him a valuable asset in his current position at W.Lan Holding GmbH, where he focuses on advisory and new ventures.56